12/13/2023 12:51:33 PM - This UK-based Chemicals - Specialty firm gapped down today promptly negating the prior gap up gain after hitting a new all-time high. Through Sep &#39;23 its 8 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>12/12/2023 12:55:31 PM - This UK-based Chemicals - Specialty firm gapped up today hitting a new all-time high. Through Sep &#39;23 its 8 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>11/7/2023 12:55:59 PM - This UK-based Chemicals - Specialty firm is pulling back today after 8 consecutive gains to reach a new all-time high. Through Sep &#39;23 its 8 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>9/15/2023 12:34:44 PM - This UK-based Chemicals - Specialty firm is hovering near its all-time high. Through Jun &#39;23 its 7 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>7/5/2023 11:57:32 AM - This UK-based Chemicals - Specialty firm is pulling back from its all-time high with a gap down today. Through Mar &#39;23 its 6 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>6/16/2023 12:51:32 PM - This UK-based Chemicals - Specialty firm is perched at its all-time high today. Through Mar &#39;23 its 6 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>2/27/2023 12:40:45 PM - This UK-based Chemicals - Specialty firm tested its 200 DMA line ($307) in January and is perched near its all-time high today after 4 consecutive volume-driven gains. Through Dec &#39;22 its 5 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>1/18/2023 12:53:05 PM - This UK-based Chemicals - Specialty firm tested its 200 DMA line ($305) and is consolidating near its 50 DMA line ($329) today. Encountered distributional pressure since noted with caution in the 11/28/22 mid-day report perched near its all-time high - <i>"Through Sep &#39;22 its 4 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady."</i><br><hr>1/5/2023 12:16:52 PM - This UK-based Chemicals - Specialty firm is testing its 200 DMA line after gapping down today. Encountered distributional pressure since last noted with caution in the 11/28/22 mid-day report perched near its all-time high - <i>"Through Sep &#39;22 its 4 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady."</i><br><hr>11/28/2022 12:31:53 PM - This UK-based Chemicals - Specialty firm is perched within striking distance of its all-time high after 9 consecutive weekly gains. Through Sep &#39;22 its 4 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.<br><hr>5/26/2022 2:33:46 PM - This UK-based Chemicals - Specialty firm is consolidating just above its 50 and 200 DMA lines. Through Mar &#39;22 its 2 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria).  Annual earnings (A criteria) history has been steady.<br><hr>2/4/2022 12:36:34 PM - This UK-based Chemicals - Specialty firm gapped down today violating its 200 DMA line ($310). Retreated from its all-time high after wedging higher with gains lacking great volume conviction since noted in the 12/03/21 mid-day report - <i>&quot;Through Sep &#39;21 its 3 latest quarterly earnings comparisons versus the year ago periods were above the +25% minimum guideline (C criteria).  Annual earnings (A criteria) history has been steady.&quot;</i><br><hr>1/31/2022 12:47:48 PM - This UK-based Chemicals - Specialty firm has been finding support near its 200 DMA line ($309.82). Retreated from its all-time high after wedging higher with gains lacking great volume conviction since noted in the 12/03/21 mid-day report - <i>&quot;Through Sep &#39;21 its 3 latest quarterly earnings comparisons versus the year ago periods were above the +25% minimum guideline (C criteria).  Annual earnings (A criteria) history has been steady.&quot;</i><br><hr>1/24/2022 12:43:41 PM - This UK-based Chemicals - Specialty firm is slumping below its 200 DMA line ($309) with today&#39;s loss. Abruptly retreating from its all-time high after wedging higher with gains lacking great volume conviction since last noted in the 12/03/21 mid-day report - <i>&quot;Through Sep &#39;21 its 3 latest quarterly earnings comparisons versus the year ago periods were above the +25% minimum guideline (C criteria).  Annual earnings (A criteria) history has been steady.&quot;</i><br><hr>12/3/2021 12:45:48 PM - This UK-based Chemicals - Specialty firm is extended from any sound base and consolidating above its 50 DMA line near its all-time high.  Through Sep &#39;21 its 3 latest quarterly earnings comparisons versus the year ago periods were above the +25% minimum guideline (C criteria).  Annual earnings (A criteria) history has been steady.<br><hr>9/25/2020 12:52:32 PM - Pulled back and violated its 50 DMA line with damaging volume-driven losses since last noted with caution in the 7/16/20 mid-day report - <i>&quot;This UK-based Chemicals -  Specialty firm through Mar &#39;20 has a quarterly and annual earnings (C and A criteria) history that has been erratic.&quot;</i><br><hr>7/16/2020 12:59:16 PM - Hitting new 52-week and all-time highs with today&#39;s 3rd consecutive gain. Pulled back and found support near its 200 DMA line and rebounded impressively since last noted with caution in the 6/08/20 mid-day report - <i>&quot;This UK-based Chemicals -  Specialty firm through Mar &#39;20 has a quarterly and annual earnings (C and A criteria) history that has been erratic.&quot;</i><br><hr>6/8/2020 12:24:06 PM - Pulling back today after challenging its 52-week and all-time highs on the prior session when noted with caution in the mid-day report - <i>&quot;This UK-based Chemicals -  Specialty firm through Mar &#39;20 has a quarterly and annual earnings (C and A criteria) history that has been erratic.&quot;</i><br><hr>6/5/2020 1:03:21 PM - Gapped up today challenging its 52-week and all-time highs. This UK-based Chemicals -  Specialty firm through Mar &#39;20 has a quarterly and annual earnings (C and A criteria) history that has been erratic.<br><hr>12/2/2019 12:02:45 PM - Gapped down today. This UK-based Chemicals -  Specialty firm, through Sep &#39;19, has a quarterly and annual earnings (C and A criteria) history that has been erratic.<br><hr>5/10/2019 12:51:13 PM - This UK-based Chemicals -  Specialty firm, through Mar &#39;19, has a quarterly and annual earnings (C and A criteria) history that has been erratic.<br><hr>